Xirtam H Combination In the Treatment of Hypertension Evaluation Study.
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This is post-marketing observational study in which data on safety and effectiveness of
Xirtam H will be collected from routine clinical practice. The study objectives are to
investigate the effect of Xirtam-H on blood pressure and achievement of target blood pressure
as well as safety and satisfaction of treatment. All hypertensive patients (Blood pressure >
140/90 mmHg) where investigator feels that addition of Xirtam H would be beneficial to
patients will be included in non interventional study. The routine investigation suggested by
the attending physician will be done in patients of hypertension. No additional investigation
will be done for the study purpose. The patient not controlled on existing treatment and
prescribed Xirtam H will be included in study after taking the informed consent. The patient
will be followed up for 2-follow up visit each after 6 weeks. The physical examination,
routine investigation, blood pressure measures will be done and the data will be entered in
the CRF as mentioned in CRF in each visit. The study is planned to be carried out in 9604
patients from around 300 - 350 trial sites in India.